MEI Pharma Inc
NASDAQ:LITS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
MEI Pharma Inc
NASDAQ:LITS
|
US |
|
U
|
Universal Health Services Inc
F:UHS
|
US |
|
C
|
Compass Minerals International Inc
XBER:CM8
|
US |
|
Bayan Resources Tbk PT
F:BNB
|
ID |
|
M
|
MS&AD Insurance Group Holdings Inc
XMUN:59M
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LITS's stock price target?
Not Available
LITS does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for MEI Pharma Inc?
Projected CAGR
-27%
The compound annual growth rate for Revenue over the next 3 years is -27%.